Kesebir, A. O. Et Al. 2022. Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY , vol.69, no.3 , 1275-1283.

Kesebir, A. O., GÜLLER, P., KALIN, R., ÖZDEMİR, H., & KÜFREVİOĞLU, Ö. İ., (2022). Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY , vol.69, no.3, 1275-1283.

Kesebir, Arzu Et Al. "Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results," BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY , vol.69, no.3, 1275-1283, 2022

Kesebir, Arzu O. Et Al. "Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results." BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY , vol.69, no.3, pp.1275-1283, 2022

Kesebir, A. O. Et Al. (2022) . "Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results." BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY , vol.69, no.3, pp.1275-1283.

@article{article, author={Arzu Ozturk Kesebir Et Al. }, title={Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results}, journal={BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY}, year=2022, pages={1275-1283} }